Transgene
Designs and develops viral-based immunotherapies.
Launch date
Employees
Market cap
€138m
Enterprise valuation
€123m (Public information from Sep 2024)
Share price
€1.022 TNG.PA
Illkirch Grand Est (HQ)
Authorizing premium user...